Form 4 for ALLO Allogene Therapeutics, Inc.
Accepted 2026-06-23 16:35:15 ET · period of report 2026-06-18 · accession 0001221355-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-23 16:35 | 2026-06-18 | ALLO | Kazam Joshua A | Dir | M - OptEx | $0.00 | +47.7K | 398.5K | +14% | $0 |
| D | 2026-06-23 16:35 | 2026-06-18 | ALLO | Kazam Joshua A | Dir | M - OptEx | $0.00 | -47.7K | 0 | -100% | $0 |
| D | 2026-06-23 16:35 | 2026-06-18 | ALLO | Kazam Joshua A | Dir | A - Grant | $0.00 | +95.4K | 95.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-18 | M | A | 47,700 | $0.00 | 398,463 | D | — | — | |
| 2 | Derivative | Restricted Stock Unit | 2026-06-18 | M | D | 47,700 | $0.00 | 0 | D | — · — to — | 47,700 Common Stock | (F1) Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2018 Plan. (F2) Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. (F2) Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. |
| 3 | Derivative | Restricted Stock Unit | 2026-06-18 | A | A | 95,400 | $0.00 | 95,400 | D | — · — to — | 95,400 Common Stock | (F2) Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. (F2) Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. (F2) Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in two successive equal semi-annual installments over the one-year period measured from the date of grant, subject to continued service through the vesting date. |